Interaction of increasing ICU survival and admittance policies in patients with hematologic neoplasms: A single center experience with 304 patients, Eur J Haematol, vol.102, pp.265-74, 2019. ,
Managing critically Ill hematology patients: Time to think differently, Blood Reviews, vol.29, pp.359-67, 2015. ,
Predictors of outcome in patients with hematologic malignancies admitted to the intensive care unit, Hematology/Oncology and Stem Cell Therapy, vol.11, pp.206-224, 2018. ,
Time trend analysis of long term outcome of patients with haematological malignancies admitted at dutch intensive care units, Br J Haematol, vol.181, pp.68-76, 2018. ,
Mortality of Patients with Hematological Malignancy after Admission to the Intensive Care Unit, Onkologie, vol.35, pp.556-61, 2012. ,
Letalität hämatoonkologischer Patienten in Neutropenie auf der Intensivstation, Med Klin Intensivmed Notfmed, vol.111, pp.84-91, 2016. ,
Changes in critically ill cancer patients' short-term outcome over the last decades: results of systematic review with meta-analysis on individual data, Intensive Care Med, vol.45, pp.977-87, 2019. ,
Mortality of Oncohematological Patients Undergoing Hematopoietic Stem Cell Transplantation Admitted to the Intensive Care Unit, Transplantation Proceedings, vol.47, pp.2665-2671, 2015. ,
Impact of organ dysfunction on mortality in ICU patients with hematologic malignancies, Intensive Care Med, vol.36, pp.1744-50, 2010. ,
Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies, Intensive Care Med, vol.34, pp.847-55, 2008. ,
Allogeneic stem cell transplantation recipients requiring intensive care: time is of the essence, Ann Hematol, vol.97, pp.1601-1610, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01812041
, La commission d'éthique de la soc, la société de réanimation en lang, le groupe francophone de réanimat. Aspects cliniques et éthiques du transfert en réanimation des patients porteurs d'hémopathies malignes, Réanimation, vol.19, pp.699-705, 2010.
Outcomes of Critically Ill Patients With Hematologic Malignancies: Prospective Multicenter Data From France and Belgium-A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study, JCO, vol.31, pp.2810-2818, 2013. ,
Outcomes of hospitalized hematologic oncology patients receiving rapid response system activation for acute deterioration, Crit Care, vol.23, p.286, 2019. ,
The intensive care support of patients with malignancy: do everything that can be done, Intensive Care Med, vol.32, pp.3-5, 2006. ,
Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU, Intensive Care Med, vol.32, pp.1560-1568, 2006. ,
Multiple organ failure and outcome of critically ill patients with haematological malignancy, Acta Anaesthesiol Scand, vol.47, pp.301-307, 2003. ,
Outcomes in critically ill patients with hematologic malignancies who received renal replacement therapy for acute kidney injury in an intensive care unit, Journal of Critical Care, vol.26, pp.107-108, 2011. ,
Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortality, European Journal of Internal Medicine, vol.22, pp.57-61, 2011. ,
Prognosis-related factors in intensive care unit (ICU) patients with hematological malignancies: A retrospective cohort analysis in a Chinese population, Hematology, vol.20, pp.494-503, 2015. ,
Prognostic factors in critically ill patients with hematological malignancy admitted to the general intensive care unit: a single-center experience in Japan, J Anesth, vol.31, pp.736-779, 2017. ,
The prognostic value of a trend in modified SOFA score for patients with hematological malignancies in the intensive care unit, Eur J Haematol, vol.99, pp.315-337, 2017. ,
Determinants of 6-month survival of critically ill patients with an active hematologic malignancy, Journal of Critical Care, vol.36, pp.252-260, 2016. ,
Hematologic malignancies in the medical intensive care unit -Outcomes and prognostic factors, Hematology, vol.20, pp.247-53, 2015. ,
Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication, Crit Care Med, vol.31, pp.104-116, 2003. ,
Outcome and Prognostic Factors in Patients with Hematologic Malignancies Admitted to the Intensive Care Unit: A Single-Center Experience, International Journal of Hematology, vol.85, pp.195-202, 2007. ,
Outcome and prognostic features of intensive care unit treatment in patients with hematological malignancies, Intensive Care Med, vol.28, pp.1294-300, 2002. ,
Outcome of critically ill patients with hematological malignancies, Ann Hematol, vol.92, pp.699-705, 2013. ,
Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study, British Journal of Anaesthesia, vol.108, pp.452-461, 2012. ,
Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit, Journal of Critical Care, vol.27, pp.739-740, 2012. ,
Short-and longterm outcomes in onco-hematological patients admitted to the intensive care unit with classic factors of poor prognosis, Oncotarget, vol.7, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01850431
Outcomes in adult critically Ill cancer patients with and without neutropenia: a systematic review and meta-analysis of the Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH), Oncotarget, vol.8, 2017. ,
Acute kidney injury in critically ill patients with haematological malignancies: results of a multicentre cohort study from the Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie, Nephrol Dial Transplant, vol.30, pp.2006-2019, 2015. ,
Predictors of Poor Outcomes in Critically Ill Adults with Hematologic Malignancy, Canadian Respiratory Journal, vol.2016, pp.1-7, 2016. ,
Neurological failure in ICU patients with hematological malignancies: A prospective cohort study, PLoS ONE, vol.12, p.178824, 2017. ,
Outcome of patients with ,